NCIRE - The Veterans Health Research Institute Home  |  Sitemap  |  Intranet  

Give Now
About NCIRE Support Our Mission Careers at NCIRE Contact Us The NCIRE Community - Researchers at Work
About NCIRE - The Veterans Health Research Institute
NCIRE's Impact on Veterans Veteran's Health Research Researchers by Name
There's no question that the San Francisco VA Medical Center, with the support of NCIRE, plays a major role in advancing veterans health care through research. The excellence of our NCIRE and SFVAMC investigators, all of whom are UC San Francisco faculty members, is fundamental to our success in developing cutting edge knowledge that will advance medical treatments of veterans and others, both locally and worldwide.

Paul Volberding, MD
Chair, NCIRE Board of Directors
Chief of Medicine, SFVAMC

Contact Us
Inquire Online
Email NCIRE
Give Now
Lilly Y.W. Bourguignon, PhD

Career Scientist, Medical Service, SFVAMC
Professor of Medicine, UCSF
Email: lilly.bourguignon@ucsf.edu

Cancer Cell Biology

Dr. Bourguignon is a cell biologist who has used a variety of biochemical, immunological and molecular biological techniques to elucidate the role of the protein CD44 in regulating the progression of human solid tumors, including breast cancer, ovarian cancer, prostate cancer, and head and neck squamous cell carcinoma. Her research studies also evaluate CD44 and various signaling molecules as markers for the propensity of solid tumors to spread; such markers would aid in assessing prognosis and diagnosis. Furthermore, she has developed several novel strategies to inhibit CD44-mediated signaling events and solid tumor progression. Her research could establish CD44 and associated signaling molecules as important tumor markers for early detection and evaluation of cancer, and could potentially allow the development of new drugs. Most importantly, the new information obtained from Dr. Bourguignon's cancer research program will have important clinical utility for the diagnosis, prognosis, and treatment of veteran patients, and therefore is highly relevant to the mission of SFVAMC.

Bourguignon LYW. 2008. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Sem Cancer Biol 18:251-259.

Bourguignon LYW, Xia W, Wong G. 2009. Hylauronan-mediated CD44 interaction with p300 and SIRT1 regulates ?-catenin signaling and NF?B-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem 284:2657-2671.

Education

BS, Plant Pathology, National Taiwan University

MA, Developmental Biology, State University of New York at Stony Brook
PhD, Developmental Biology, State University of New York at Stony Brook Executive MBA, University of Miami

Awards & Honors

State University of New York at Stony Brook Graduate Fellowship, 1969-1973

NIH Postdoctoral Fellowship, 1975-1977
Established Investigatorship - American Heart Association, 1984-1989
First Provost Scholarly Activity Award, 1997